Preclinical Study PK & Oxidative Stress Reduction

Preclinical Study PK & Oxidative Stress Reduction

In a preclinical study completed in November of 2023 by Dr. José Trinidad Pérez Urizar, Ph.D. a professor in the Biomedical Sciences Department of the University of San Luis Potosí. The preclinical study’s objective was to characterize the systemic bioavailability of the metal ions - Magnesium (Mg+2), Zinc (Zn+2), and Copper (Cu+2) contained in the active ingredient ION-ZCM1 (solution) and Ion Gel ZCM-25®. Injectable and topical protocols were administered in single and multiple doses in experimental models, using 160 mice and 10 rabbits.

The results obtained in rabbits after topical application of Ion Gel ZCM-25® indicate a high bioavailability of the Magnesium (Mg+2), Zinc (Zn+2), and Copper (Cu+2) cations in the blood, showing a systemic absorption in the first hour of application.

Additionally, the pharmacokinetic profile of this study indicated that there is no accumulation of the metal ions. This is relevant data regarding cellular toxicity, establishing a safe pharmacokinetic profile over the study period.

The results obtained on the topical application of Ion Gel ZCM-25® as its antioxidant capacity (FRAP) after a single dose (401,793)  and double doses (414,816) in terms of the antioxidant index were higher than the control (386,496), confirming its high reducing capacity by electron transfer in the first hours of application. 

    • Related Articles

    • Hydrogen a Critical Element in Cancer Care

      Hydrogen is the most prevalent element in the universe and the deciding factor in life. Hydrogen exists on Earth in many compounds, such as water, the most abundant mixture on Earth. It also exists in almost all organic compounds, making up about 61 ...

    • Phase I study to determine the topical tolerability of Ion Gel ZCM-25®.

      To evaluate the tolerability of the product Ion Gel ZCM-25®, measured as the degree of irritability: edema and/or erythema, during 14 days of administration in healthy subjects. Methods. Twenty research subjects of both sexes were recruited, a dose ...

    • Dermal Irritability Single High Dose Study of Ion Gel ZCM-25® on New Zealand Male Rabbits

      Abstract Study Title: Dermal Irritability Single High Dose Study of Ion Gel ZCM-25® on New Zealand Male Rabbits Author: UNAM - Preclinical Research Unit - UNIPREC - Dr. Azucena Ibeth Carballo Villalobos (Principal Investigator) (2019). Methods: A ...

    • ION-ZC1 Antimicrobial Study 3 - MRSA in Biofilm

      Abstract Study Title: ION-ZC1 Antimicrobial Study 3 - MRSA in Biofilm Author: INDEVION Biotechnology Research and Development Ltd. Principal Investigator Dr. Zsolt Keresztessy, Ph.D. (2017). Methods: ION-ZC1 antimicrobial study report 3 evaluating ...

    • Ion Gel ZCM-25® Phase 1 Clinical Study on Humans

      Abstract In the present Ion Gel ZCM-25® Phase 1 Clinical Study on Humans, the tolerability of the Class II Medical Device, Ion Gel ZCM-25® was evaluated after daily administration for 14 days, the dose of 0.5mL on the intact skin of the left arm of ...